SBIR/STTR Research Award
Commercialization of a Microscale, Point-of-Use Radiosynthesis Device for the Development and Production of PET Probes
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2011Award details
- Awarding agency
- Department of Energy
- Branch
- Not reported
- Recipient company
- Sofie Biosciences, Inc.
- Proposal award date
- 2011-06-17
- Contract end date
- 2012-05-16
- UEI
- Not reported
- Solicitation number
- DE-FOA-0000413
- Topic code
- 33 a
Research abstract
Positron Emission Tomography (PET) is a molecular imaging modality that utilizes radiolabeled molecules (probes) to target and measure biological processes. Basic scientists can use the same probes to examine microorganisms, cells, and mice as they do in patients to visualize and characterize the biology of disease, monitor its progression, and evaluate therapeutic efficacy. Although over 1,600 PET probes have been developed to help answer a variety of biological questions, only the glucose analog ([18F] FDG) is routinely used. This limitation exists because of the centralized radiopharmacy approach to PET probe production, with its complexity, high infrastructure cost, and necessity of specialized equipment and skilled personnel. A decentralized approach to PET probe development is required to give scientists the freedom to determine what probes they want to use to best solve the problems of their interest. This goal can be achieved by building a benchtop, PC-controlled, microfluidic chip-based commercial device for the on-demand production of PET probes. Phase I of this project will answer basic commercial feasibility questions about the underlying Electro-Wetting-On-Dielectric (EWOD) microfluidic chip technology, while Phase II will produce a commercial prototype of the device, complete with a PC-based control system that contains an inexpensive, disposable, probe-specific cartridge of the microfluidic chip and associated reagents. As an eventual product, a library of chips will be developed based on customer needs for different probes. Shifting to a point-of-research/point-of-care model is a transformational solution that removes the limitations imposed by the centralized model on probe production, cost, and diversity. By empowering scientists and clinicians to control the development and use of PET probes, they are able to focus on processes that they believe are most important for the environmental and biological sciences.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- (33a)Development of Non-Linear Inserts for IOTA Ring at Fermilab
- Plasma Photocathode Beam Brightness Transformer for Laser-Plasma Accelerators
- Commercialization of a Microscale, Point of Use Radiosynthesis Device for the Development and Production of PET Probes
- Integrated Use of Surface and Subsurface NMR for Measuring and Mapping Saturated Hydraulic Conductivity in Three Dimensions
- Isotope Hygrometer for in situ Subsurface Characterization